These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29658988)

  • 21. Fine needle aspiration cytology of Merkel cell carcinoma.
    Kabukcuoglu F; Sungun A; Polat N; Evren I; Kabukcuoglu Y
    Acta Cytol; 2003; 47(2):311-3. PubMed ID: 12685207
    [No Abstract]   [Full Text] [Related]  

  • 22. Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease.
    Izbéki F; Nagy F; Szepes Z; Kiss I; Lonovics J; Molnár T
    Inflamm Bowel Dis; 2008 Mar; 14(3):429-31. PubMed ID: 17973302
    [No Abstract]   [Full Text] [Related]  

  • 23. [Merkel cell carcinoma in elderly].
    Koljonen V; Tarkkanen M; Tukiainen E; Böhling T
    Duodecim; 2005; 121(20):2205-13. PubMed ID: 16457190
    [No Abstract]   [Full Text] [Related]  

  • 24. Post-marketing study of biosimilar infliximab (CT-P13) to evaluate its safety and efficacy in Korea.
    Park SH; Kim YH; Lee JH; Kwon HJ; Lee SH; Park DI; Kim HK; Cheon JH; Im JP; Kim YS; Lee SY; Lee SJ
    Expert Rev Gastroenterol Hepatol; 2015; 9 Suppl 1():35-44. PubMed ID: 26395533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unknown primary Merkel cell carcinoma responding well to first-line treatment with avelumab.
    Hanai S; Shimauchi T; Kageyama R; Aoshima M; Ito T; Tokura Y
    J Dermatol; 2019 Aug; 46(8):e273-e275. PubMed ID: 30802319
    [No Abstract]   [Full Text] [Related]  

  • 26. Predictors of infliximab failure after azathioprine withdrawal in Crohn's disease treated with combination therapy.
    Oussalah A; Chevaux JB; Fay R; Sandborn WJ; Bigard MA; Peyrin-Biroulet L
    Am J Gastroenterol; 2010 May; 105(5):1142-9. PubMed ID: 20389296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral tubercular lesions in a patient treated with infliximab for Crohn's disease.
    Galati V; Grilli E; Busi Rizzi E; Prantera C; Petrosillo N
    J Neurol; 2008 Dec; 255(12):1981-2. PubMed ID: 18854914
    [No Abstract]   [Full Text] [Related]  

  • 28. Recurrent Fevers After Infliximab Therapy for Ulcerative Colitis.
    Ma C; Fedorak RN; Halloran BP
    Gastroenterology; 2016 Jan; 150(1):e1-2. PubMed ID: 26627333
    [No Abstract]   [Full Text] [Related]  

  • 29. Avoiding infliximab in the treatment of Crohn's disease in patients with multiple sclerosis.
    Nanavati SA; Ergun GA; Schwartz JT
    Am J Gastroenterol; 2003 Oct; 98(10):2333-4. PubMed ID: 14572598
    [No Abstract]   [Full Text] [Related]  

  • 30. Posterior Reversible Encephalopathy Syndrome in a Patient With Crohn's Disease on Infliximab.
    Chow S; Patnana S; Gupta NK
    J Clin Gastroenterol; 2016 Sep; 50(8):687. PubMed ID: 27306938
    [No Abstract]   [Full Text] [Related]  

  • 31. Biosimilar infliximab (CT-P13) in the treatment of inflammatory bowel disease: A Norwegian observational study.
    Jahnsen J; Detlie TE; Vatn S; Ricanek P
    Expert Rev Gastroenterol Hepatol; 2015; 9 Suppl 1():45-52. PubMed ID: 26395534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What can primary cutaneous neuroendocrine carcinomas with squamoid and neuroendocrine differentiation teach us about the origin of Merkel cells?
    Dadzie O; Teixeira F
    Int J Dermatol; 2009 Jan; 48(1):91-3. PubMed ID: 19126060
    [No Abstract]   [Full Text] [Related]  

  • 33. Occurrence of hepatoxicicty and elevated liver enzymes in a Crohn's disease patient treated with infliximab.
    Moum B; Konopski Z; Tufteland KF; Jahnsen J
    Inflamm Bowel Dis; 2007 Dec; 13(12):1584-6. PubMed ID: 17663423
    [No Abstract]   [Full Text] [Related]  

  • 34. Differentiating Merkel cell carcinoma of lymph nodes without a detectable primary skin tumor from other metastatic neuroendocrine carcinomas: The ELECTHIP criteria.
    Kervarrec T; Zaragoza J; Gaboriaud P; Le Gouge A; Beby-Defaux A; Le Corre Y; Hainaut-Wierzbicka E; Aubin F; Bens G; Michenet P; Maillard H; Touzé A; Samimi M; Guyétant S
    J Am Acad Dermatol; 2018 May; 78(5):964-972.e3. PubMed ID: 29180096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infliximab-induced thrombocytopenia in an elderly patient with ileocolonic Crohn's disease.
    Mocciaro F; Russo G; Di Mitri R; Marino A
    Inflamm Bowel Dis; 2013; 19(4):E52-3. PubMed ID: 22535599
    [No Abstract]   [Full Text] [Related]  

  • 36. Complementary role of positron emission tomography in merkel cell carcinoma.
    Lin O; Thomas A; Singh A; Greenspan B
    South Med J; 2004 Nov; 97(11):1110-2. PubMed ID: 15586604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anti-TNF antibodies in the treatment of inflammatory intestinal stenoses in Crohn's disease].
    Holtmann M; Wanitschke R; Helisch A; Bartenstein P; Galle PR; Neurath M
    Z Gastroenterol; 2003 Jan; 41(1):11-7. PubMed ID: 12541166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lamivudine resistance and exacerbation of hepatitis B in infliximab-treated Crohn's disease patient.
    Esteve M; Loras C; González-Huix F
    Inflamm Bowel Dis; 2007 Nov; 13(11):1450-1. PubMed ID: 17712837
    [No Abstract]   [Full Text] [Related]  

  • 39. Recurrent drug-induced ANCA vasculitis in a patient with Crohn's colitis treated with infliximab: a potential contraindication to immunosuppressive therapy.
    Rosen DR; Cologne KG; Popek SM; Sung BC; Ortega AE; Senagore AJ
    Am Surg; 2012 Dec; 78(12):1406-8. PubMed ID: 23265134
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical and dermoscopic features of combined cutaneous squamous cell carcinoma (SCC)/neuroendocrine [Merkel cell] carcinoma (MCC).
    Suárez AL; Louis P; Kitts J; Busam K; Myskowski PL; Wong RJ; Chen CS; Spencer P; Lacouture M; Pulitzer MP
    J Am Acad Dermatol; 2015 Dec; 73(6):968-75. PubMed ID: 26433246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.